Neovasc IncTSX: NVCN

Neovasc Announces Year End 2017 Financial Results Conference Call and Webcast

· Issued by Neovasc Inc via CNW

NASDAQ, TSX: NVCN

VANCOUVER, March 21, 2018 /CNW/ - Neovasc, Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN), a leader in the development of minimally invasive transcatheter mitral valve replacement technologies, today announced that it will report financial results for the year ended December 31, 2017 and host a conference call and webcast at 4:30pm Eastern Time on Wednesday, March 28, 2018.

Conference Call & Webcast
Wednesday, March 28th @ 4:30pm Eastern Time

Domestic:

800-281-7973

International:

323-794-2093

Passcode:

4395026

Webcast:

http://public.viavid.com/index.php?id=128910

Replays available through April 10:

Domestic:

844-512-2921

International:

412-317-6671

Conference ID:

4395026

About Neovasc Inc.
Neovasc is a specialty medical device company that develops, manufactures and markets products for the rapidly growing cardiovascular marketplace. Its products include the Neovasc Reducer™, for the treatment of refractory angina, which is not currently available in the United States and has been available in Europe since 2015, and the Tiara™, for the transcatheter treatment of mitral valve disease, which is currently under clinical investigation in the United States, Canada and Europe.  For more information, visit: www.neovasc.com.

SOURCE Neovasc Inc.

View original content: http://www.newswire.ca/en/releases/archive/March2018/21/c2027.html

Chris Clark, Chief Financial Officer, Neovasc Inc., 604 248-4138, cclark@neovasc.com; Jeremy Feffer, LifeSci Advisors, LLC, 212-915-2568Copyright CNW Group 2018

View original source (CNW)Neovasc Inc on 6ix

Later from Neovasc

All Neovasc news releases